Feedback / Questions
ATNM-400 - Actinium
https://www.prnewswire.com/news-releases/actinium-highlights-expanded-data-set-for-atnm-400-in-prostate-cancer-demonstrating-superior-efficacy-to-enzalutamide-and-ability-to-overcome-resistance-to-arpi-therapy-and-psma-ac-225lu-177-labelled-radiotherapy-at-the-society-o-302488334.html
Jun 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next